SAIC Board of Directors Declares Cash Dividend
RESTON, Va., Aug. 30, 2024 (GLOBE NEWSWIRE) — Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board […]
Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness
For the second year, Emergent is teaming up with pro football legend, Emmitt Smith, to educate communities on opioid risks […]
Western Investment Company Revises Previously Announced Transaction
Revised Transaction Begins with Backstopped Rights Offering and Private Placement Revised Transaction Does Not Require Shareholder Approval and therefore Annual […]
Mosaic débute ses travaux d’explorations sur Mirabelli SM
MONTRÉAL, 30 août 2024 (GLOBE NEWSWIRE) — Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” ou “La Société”) annonce le début de […]
Mosaic Begins Exploration Work on Mirabelli SM
MONTREAL, Aug. 30, 2024 (GLOBE NEWSWIRE) — Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “the Company”) announces the start of […]
NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September
NAARDEN, The Netherlands and MIAMI, Aug. 30, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or […]
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
IRVINE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on […]
BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
SUNNYVALE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics […]
Cellebrite Announces “Redemption Fair Market Value” in Connection with Redemption of All Outstanding Warrants
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 30, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the […]
HOOKIPA Pharma Announces Board of Directors Changes
NEW YORK and VIENNA, Aug. 30, 2024 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK) (“HOOKIPA” or the “Company”), a […]
